Article
CNPY4 is a potential promising prognostic-related biomarker and correlated with immune infiltrates in gliomas.
Medicine - 19 Aug 2022
Li Jian-Wen, Huang Qian-Rong, Mo Li-Gen
Abstract excerpt
Glioblastomas are classified into primary and secondary; primary glioblastomas develop rapidly and aggressively, whereas secondary glioblastomas are more common in grade II and III gliomas. Here, we aimed to demonstrate the role of the CNPY4 gene as a potential biomarker in immune infiltration in gliomas. Based on gene expression profile interaction analysis (GEPIA), we studied the survival model of CNPY4 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
